Influenza C virusassociated community-acquired pneumonia in children

Insights

Influenza C virus (ICV) infection can cause severe community-acquired pneumonia (CAP) in children, similar to influenza A virus (IAV) but worse than influenza B virus (IBV). This study confirms ICV as a cause of pediatric CAP requiring hospitalization.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Respiratory medicine

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of childhood morbidity.
  • Influenza viruses, including influenza A (IAV) and B (IBV), are known causes of pediatric respiratory illness.
  • The role of influenza C virus (ICV) in pediatric CAP remains less understood.

Purpose of the Study:

  • To investigate the prevalence and clinical impact of influenza C virus (ICV) infection in children diagnosed with community-acquired pneumonia (CAP).
  • To compare the clinical presentation and severity of ICV-associated CAP with CAP caused by other influenza strains (IAV and IBV).

Main Methods:

  • Prospective evaluation of children with radiographically confirmed CAP over four influenza seasons.
  • Detection of ICV in respiratory secretions using molecular methods.
  • Comparison of clinical data between children with ICV-associated CAP and those with IAV- or IBV-associated CAP.
  • Phylogenetic analysis of sequenced ICV strains.

Main Results:

  • ICV was identified in 1.3% (5/391) of children with CAP.
  • Clinical manifestations of ICV-associated CAP were comparable to IAV-associated CAP.
  • Children with ICV-associated CAP exhibited more severe symptoms than those with IBV-associated CAP.
  • Sequenced ICV strains belonged to two distinct lineages.

Conclusions:

  • Influenza C virus is a causative agent of community-acquired pneumonia in children.
  • ICV-associated CAP can be severe, necessitating hospitalization.
  • Further research into ICV pathogenesis and epidemiology is warranted.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...